Sharon Choe

Sharon Choe serves as the Chief Communications Officer at Curtana Pharmaceuticals, bringing over 30 years of strategic Wall Street and healthcare experience to the leadership team. A seasoned financial professional, she has served as a healthcare analyst and equity portfolio manager for prominent buy-side institutional banks, including UBS Asset Management and Credit Suisse Asset Management, as well as the derivative hedge fund BAM Capital.

Sharon’s extensive background in investor relations includes leadership roles both in-house for a retinal rare diseases company and externally with several premier Life Sciences IR agencies, such as LifeSci Advisors and The Ruth Group. Currently, she also serves as a Managing Partner at Private Office Ventures, where she oversees a prestigious deal flow valued at $14 billion across diverse sectors including oncology-focused healthcare, venture capital, and high tech. Sharon earned her B.S. degree in Pharmacy from Northeastern University, providing her with a foundational clinical perspective that complements her deep financial and communications expertise